Regulatory: what is a CTA or IND application?
Course
About course
This free online course explores the clinical trial application (CTA), a part of the regulatory process when seeking new drug or biologics approval. The CTA, known as the investigational new drug (IND) application in the US, is used to demonstrate that a proposed clinical trial can be carried out safely in humans.
Key learnings:
- What information is required to submit the CTA/IND to the relevant regulatory body
- The main differences between the various types of CTAs, including IND
- How to avoid common issues and delays
You’ll get insights on CTAs/INDs from one of our experts on the topic as well as find links to supporting resources. If you come across unfamiliar terms, check out the glossary of some key regulatory terms, processes, acronyms, and their definitions.
You can access and complete each lesson individually, with the full course taking around 15 minutes to complete.
Certification
You will get an online certificate after the course completion. You can view and download it in a section My Courses. With Cytiva Certificates, portions of our programs have been split into online modules, so you can earn a high quality knowledge in interactive format.
